ACRV insider buying
Every open-market purchase of Acrivon Therapeutics, Inc. (ACRV) stock by its officers, directors and major shareholders, from SEC Form 4 filings.
Bought, last 12 months$114.53K
Insiders buying (12m)3
Purchases on record3
Last purchase filedJan 16, 2026
In the last 12 months, 3 insiders of Acrivon Therapeutics, Inc. bought $114.53K of ACRV stock on the open market in 3 reported purchases. The most recent was filed on Jan 16, 2026: Blume-Jensen Peter +1 (President and CEO, Director) bought 49,000 shares at $1.68, worth $82.32K.
Get the next ACRV insider buy on TelegramFree daily recap of the biggest insider purchases, straight from SEC filings. Real-time alerts for Premium members.
Join free on Telegram